Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The PUBLIC FUND FOR STRENGTHENING CHILDREN has issued a Tender notice for the procurement of a Purchase of Imiglucerase 400 Tb (Effect Unit) for the Republican Specialized Pediatric Scientific and Applied Medical Center in the Uzbekistan. This Tender notice was published on 05 Aug 2026 and is scheduled to close on 20 Aug 2026, with an estimated Tender value of UZS 26990000004.24. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 146588695, while the tender notice number is 26111006505757 and Registering on the platform.
Procurement Summary
Country: Uzbekistan
Summary: Purchase of Imiglucerase 400 Tb (Effect Unit) for the Republican Specialized Pediatric Scientific and Applied Medical Center
Deadline: 20 Aug 2026
Posting Date: 05 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146588695
Document Ref. No.: 26111006505757
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UZS 26990000004.24
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details Field of application It is used for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Gaucher's disease. The active substance - imiglucerase - a modified form of beta-glucocerebrosidase obtained by recombinant means is the form Imiglucerase hydrolyzes glucosylceramide, compensates for enzyme deficiency and affects the main pathophysiological mechanisms of the disease. Treatment with imiglucerase leads to a decrease in the size of the spleen and liver, platelets and helps to increase or normalize hemoglobin values, improve bone mineral density, reduce bone marrow infiltration and bone pain. Treatment of glucosylceramide accumulation in macrophages and response to therapy can reduce the level of chitotriosidase, which is a biomarker. In children, the drug helps to restore growth and sexual development indicators. Documents
Status : Eʼlon qilindi Source of funding: Jamoat Fondi Mablag'lari
Procurement Documents for Uzbekistan
Access a comprehensive library of standard procurement documents specific to Uzbekistan. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Uzbekistan
Want To Bid in This Tender?
Get Local Agent Support in Uzbekistan and 60 More Countries.
View Tenders By
Sign in with Google